-
1Academic Journal
المؤلفون: J.E. Meca-Lallana, S. Martínez Yélamos, S. Eichau, M.A. Llaneza, J. Martín Martínez, J. Peña Martínez, V. Meca Lallana, A.M. Alonso Torres, E. Moral Torres, J. Río, C. Calles, A. Ares Luque, L. Ramió-Torrentà, M.E. Marzo Sola, J.M. Prieto, M.L. Martínez Ginés, R. Arroyo, M.Á. Otano Martínez, L. Brieva Ruiz, M. Gómez Gutiérrez, A. Rodríguez-Antigüedad Zarranz, V.G. Sánchez-Seco, L. Costa-Frossard, M.Á. Hernández Pérez, L. Landete Pascual, M. González Platas, C. Oreja-Guevara
المصدر: Neurología, Vol 39, Iss 2, Pp 196-208 (2024)
مصطلحات موضوعية: Multiple sclerosis, Consensus statement, Diagnosis, Disease-modifying therapy, Recommendations, Spanish Society of Neurology, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: J.E. Meca-Lallana, S. Martínez Yélamos, S. Eichau, M.Á. Llaneza, J. Martín Martínez, J. Peña Martínez, V. Meca Lallana, A.M. Alonso Torres, E. Moral Torres, J. Río, C. Calles, A. Ares Luque, L. Ramió-Torrentà, M.E. Marzo Sola, J.M. Prieto, M.L. Martínez Ginés, R. Arroyo, M.Á. Otano Martínez, L. Brieva Ruiz, M. Gómez Gutiérrez, A. Rodríguez-Antigüedad Zarranz, V.G. Sánchez-Seco, L. Costa-Frossard, M.Á. Hernández Pérez, L. Landete Pascual, M. González Platas, C. Oreja-Guevara
المصدر: Neurología (English Edition), Vol 39, Iss 2, Pp 196-208 (2024)
مصطلحات موضوعية: Esclerosis múltiple, Consenso, Diagnóstico, Tratamiento modificador de la enfermedad, Alta eficacia, Recomendaciones, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: L. Ramió-Torrentà, J.C. Álvarez-Cermeño, R. Arroyo, B. Casanova-Estruch, O. Fernández, J.A. García-Merino, M.A. Hernández, G. Izquierdo, S. Martínez-Yélamos, J. Meca, E. Moral, J. Olascoaga, J.M. Prieto, A. Saiz
المصدر: Neurología (English Edition), Vol 33, Iss 5, Pp 327-337 (2018)
مصطلحات موضوعية: Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: J.E. Meca-Lallana, M. Fernández-Prada, E. García Vázquez, S. Moreno Guillén, S. Otero Romero, M. Rus Hidalgo, L.M. Villar Guimerans, S. Eichau Madueño, Ó. Fernández Fernández, G. Izquierdo Ayuso, J.C. Álvarez Cermeño, C. Arnal García, R. Arroyo González, L. Brieva Ruiz, C. Calles Hernández, A. García Merino, M. González Platas, M.Á. Hernández Pérez, E. Moral Torres, J. Olascoaga Urtaza, P. Oliva-Nacarino, C. Oreja-Guevara, R. Ortiz Castillo, A. Oterino, J.M. Prieto González, L. Ramió-Torrentá, A. Rodríguez-Antigüedad, A. Saiz, M. Tintoré, X. Montalbán Gairin
المصدر: Neurología, Vol 37, Iss 8, Pp 615-630 (2022)
مصطلحات موضوعية: Alemtuzumab, Effectiveness, Multiple sclerosis, Daily clinical practice, Safety, Spain, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
5Academic Journal
المؤلفون: J.E. Meca-Lallana, M. Fernández-Prada, E. García Vázquez, S. Moreno Guillén, S. Otero Romero, M. Rus Hidalgo, L.M. Villar Guimerans, S. Eichau Madueño, Ó. Fernández Fernández, G. Izquierdo Ayuso, J.C. Álvarez Cermeño, C. Arnal García, R. Arroyo González, L. Brieva Ruiz, C. Calles Hernández, A. García Merino, M. González Plata, M.Á. Hernández Pérez, E. Moral Torres, J. Olascoaga Urtaza, P. Oliva-Nacarino, C. Oreja-Guevara, R. Ortiz Castillo, A. Oterino, J.M. Prieto González, L. Ramió-Torrentá, A. Rodríguez-Antigüedad, A. Saiz, M. Tintoré, X. Montalbán Gairin
المصدر: Neurología (English Edition), Vol 37, Iss 8, Pp 615-630 (2022)
مصطلحات موضوعية: Alemtuzumab, Eficacia, Esclerosis múltiple, España, Práctica clínica habitual, Seguridad, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
6Academic Journal
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
7Academic Journal
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
8Academic Journal
المؤلفون: J E Meca-Lallana, C Oreja-Guevara, D Muñoz, J Olascoaga, A Pato, L Ramió-Torrentà, V Meca-Lallana, M A Hernández, M E Marzo, J C Álvarez-Cermeño, A Rodríguez-Antigüedad, X Montalbán, O Fernández, Spanish GILENYA Registry Investigators
المصدر: PLoS ONE, Vol 16, Iss 10, p e0258437 (2021)
Relation: https://doi.org/10.1371/journal.pone.0258437; https://doaj.org/toc/1932-6203; https://doaj.org/article/07987836f8b74fd78ad563e5d9b47c6e
-
9Academic Journal
المؤلفون: V. Casado, I. Bonaventura, L. Brieva, S. Martínez-Yélamos, G. Martín, S. Presas-Rodriguez, M. Hervas, J.J. Hernández, E. Munteis, A. Escartin, L. Gubieras, M.A. Mañé-Martínez, L. Ramió-Torrentà
المصدر: Neurology Perspectives, Vol 1, Iss 3, Pp 160-169 (2021)
مصطلحات موضوعية: Esclerosis múltiple remitente-recurrente, Costes directos de los brotes, Fármaco modificador de la enfermedad, Estudio observacional, Cataluña, España, Neurology. Diseases of the nervous system, RC346-429
Relation: http://www.sciencedirect.com/science/article/pii/S2667049621000387; https://doaj.org/toc/2667-0496; https://doaj.org/article/9ca4cfd77b8b472bb57a0ff7b25d63e8
-
10Academic Journal
المؤلفون: L. Ramió-Torrentà, J.C. Álvarez-Cermeño, R. Arroyo, B. Casanova-Estruch, O. Fernández, J.A. García-Merino, M.A. Hernández, G. Izquierdo, S. Martínez-Yélamos, J. Meca, E. Moral, J. Olascoaga, J.M. Prieto, A. Saiz
المصدر: Neurología, Vol 33, Iss 5, Pp 327-337 (2018)
مصطلحات موضوعية: Neurology. Diseases of the nervous system, RC346-429
Relation: http://www.sciencedirect.com/science/article/pii/S0213485315002698; https://doaj.org/toc/0213-4853; https://doaj.org/article/983cc4cd70074e178e69751eea4ed188
-
11Image
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
12Image
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
13Image
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
14Image
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
15Image
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
16
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
17
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
18
المؤلفون: J. E. Meca-Lallana (11559402), C. Oreja-Guevara (11559405), D. Muñoz (2950722), J. Olascoaga (11559408), A. Pato (11559411), L. Ramió-Torrentà (11559414), V. Meca-Lallana (11559417), M. A. Hernández (11559420), M. E. Marzo (11559423), J. C. Álvarez- Cermeño (11559426), A. Rodríguez-Antigüedad (11559429), X. Montalbán (11559432), O. Fernández (2950728)
مصطلحات موضوعية: Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Plant Biology, urinary tract infection, na 239, multicenter case registry, lesions progressively increased, enlarged t2 lesions, brace ), natalizumab, six evaluable patients, adequate safety results, multiple sclerosis treated, multiple sclerosis, results obtained, year safety, year 4,
%22">xlink ">, term use, significant reduction, radiological measures, previously treated, positive benefit, patients free, overall population, modifying therapy, minimal deterioration -
19Academic Journal
المؤلفون: L. Martín-Aguilar, S. Presas-Rodriguez, À. Rovira, J. Capellades, A. Massuet-Vilamajó, L. Ramió-Torrentà, M. Tintoré, L. Brieva-Ruiz, E. Moral, A. Cano-Orgaz, Y. Blanco, J. Batlle-Nadal, O. Carmona, M. Gea, J.V. Hervás-García, C. Ramo-Tello
المصدر: Neurología (English Edition), Vol 37, Iss 7, Pp 557-563 (2022)
مصطلحات موضوعية: Esclerosis múltiple, Brote, Resonancia magnética, Lesiones captantes de gadolinio, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
-
20Academic Journal
المؤلفون: Monreal, Enric, Fernández-Velasco, José Ignacio, Álvarez-Lafuente, Roberto, Sainz de la Maza, Susana, García-Sánchez, María Isabel, Llufriu, Sara, Casanova, Bonaventura, Comabella, Manuel, Martínez-Yélamos, Sergio, Galimberti, Daniela, Ramió-Torrentà, Lluís, Martínez-Ginés, María Luisa, Aladro, Yolanda, Ayuso, Lucía, Martínez-Rodríguez, José Enrique, Brieva, Luis, Villarrubia, Noelia, Eichau, Sara, Zamora, Javier, Rodero-Romero, Alexander, Espiño, Mercedes, Blanco, Yolanda, Saiz, Albert, Montalbán, Xavier, Tintoré, Mar, Domínguez-Mozo, María Inmaculada, Cuello, Juan Pablo, Romero-Pinel, Lucía, Ghezzi, Laura, Pilo de la Fuente, Belén, Pérez-Miralles, Francisco, Quiroga-Varela, Ana, Rubio, Lluïsa, Rodríguez-Jorge, Fernando, Chico-García, Juan Luís, Sainz-Amo, Raquel, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa M
المساهمون: E. Monreal, J.I. Fernández-Velasco, R. Álvarez-Lafuente, S. Sainz de la Maza, M.I. García-Sánchez, S. Llufriu, B. Casanova, M. Comabella, S. Martínez-Yélamo, D. Galimberti, L. Ramió-Torrentà, M.L. Martínez-Giné, Y. Aladro, L. Ayuso, J.E. Martínez-Rodríguez, L. Brieva, N. Villarrubia, S. Eichau, J. Zamora, A. Rodero-Romero, M. Espiño, Y. Blanco, A. Saiz, X. Montalbán, M. Tintoré, M.I. Domínguez-Mozo, J.P. Cuello, L. Romero-Pinel, L. Ghezzi, B. Pilo de la Fuente, F. Pérez-Miralle, A. Quiroga-Varela, L. Rubio, F. Rodríguez-Jorge, J.L. Chico-García, R. Sainz-Amo, J. Masjuan, L. Costa-Frossard, L.M. Villar
مصطلحات موضوعية: clinically isolated syndrome, neurofilament light chain, glial fibrillary acidic protein, progression, multiple sclerosis, Settore MEDS-12/A - Neurologia, Settore BIOS-10/A - Biologia cellulare e applicata
Relation: info:eu-repo/semantics/altIdentifier/pmid/39101570; info:eu-repo/semantics/altIdentifier/wos/WOS:001336680700001; journal:BRAIN; https://hdl.handle.net/2434/1111929